Processa Pharmaceuticals, Inc. Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Processa Pharmaceuticals, Inc. stock issued during period, shares, new issues for the quarter ending 2015-12-31 was 0.00 shares.
- Processa Pharmaceuticals, Inc. stock issued during period, shares, new issues for the quarter ending 2015-09-30 was 0.00 shares.
- Processa Pharmaceuticals, Inc. stock issued during period, shares, new issues for the quarter ending 2015-06-30 was 0.00 shares.
- Processa Pharmaceuticals, Inc. stock issued during period, shares, new issues for the quarter ending 2015-03-31 was 50.28K shares.
- Processa Pharmaceuticals, Inc. stock issued during period, shares, new issues for fiscal 2015 was 50.28K shares, a 75.98% decline from fiscal 2014.
- Processa Pharmaceuticals, Inc. stock issued during period, shares, new issues for fiscal 2014 was 209.32K shares.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2015-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-25 | 50.28K shares 10-K · filed 2017-09-25 |
| 2015-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-12-01 | |
| 2015-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-19 | |
| 2015-03-31 | 50.28K shares 10-Q · filed 2015-05-15 | |
| 2014-12-31 | 209.32K shares 10-K · filed 2015-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |